OrganOx Achieves Landmark $1.5 Billion Exit with BGF

Deal News | Aug 25, 2025 | Business Growth Fund (BGF)

OrganOx Achieves Landmark $1.5 Billion Exit with BGF

No summary available.

Sectors

  • Medtech
  • Private Equity

Geography

  • United Kingdom – The UK is central to the story as it is the location of OrganOx and relevant for the discussion on scaling UK medtech innovation.

Industry

  • Medtech – The article focuses on OrganOx, a medical technology company, and its significance in the UK medtech sector through its notable exit.
  • Private Equity – The article involves BGF, a private equity firm, highlighting its strategic investment and return through the OrganOx exit.

Financials

  • $1.5 billion – Valuation of OrganOx at the time of its exit.

Participants

NameRoleTypeDescription
OrganOxTarget CompanyCompanyA medtech firm based in the UK focused on organ preservation technologies.
Business Growth Fund (BGF)InvestorCompanyA private equity firm investing in OrganOx, achieving its largest return with the company's exit.